NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

Wake County EMS's MOUD program successfully integrates buprenorphine treatment for opioid use in prehospital care.

A University of the Pacific team has developed a single-dose injection to counter the effects of fentanyl and other opioid ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Whatcom County Health and Community Services has partnered with the Swinomish tribe’s didgʷálič Wellness Center to bring a ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

A professor and his team at University of the Pacific have developed a single-dose treatment that provides extended ...

Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company, Purdue Pharma, ...

they may decide then to continue that treatment. It is very effective, not only in treating withdrawal symptoms, but in reducing opioid use and then reducing the risk of death," he added of ...